| 1457 |
Dr. Reena Engineer |
Phase III randomized trial of high dose chemoradiation and systemic chemotherapy vs systemic chemotherapy alone in patients with unresectable nonmetastatic cholangiocarcinoma |
CTRI/2016/08/007156 |
Active Enrollment ongoing |
Radiation Oncology |
Gastro Intestinal |
| 1478 |
Dr. Avanish Saklani |
Survivorship programme for colorectal cancers patients- a randomized study |
CTRI/2018/12/016501 |
Active Enrollment ongoing |
Surgical Oncology |
Gastro Intestinal |
| 1569 |
Dr. Vikas Ostwal |
Prospective observational cohort study of advanced Gall bladder cancer patients to study the impact of clinical and molecular characteristics and outcome |
CTRI/2016/10/007343 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 1652 |
Dr. Reena Engineer |
Perioperative therapy (preop chemo v/s CTRT) in locally advanced gall bladder cancers (POLCA-GB) |
CTRI/2016/08/007199 |
Data Analysis ongoing |
Radiation Oncology |
Gastro Intestinal |
| 1667 |
Dr. Sohan Solanki |
A prospective audit of perioperative parameters of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) |
NCT02754115 |
Active Enrollment ongoing |
Anaesthesia |
Gastro Intestinal |
| 1849 |
Dr. Anant Ramaswamy |
A two arm randomized open label prospective parallel design superiority Phase II multicentric clinical trial to evaluate the efficacy of a doublet second line chemotherapy versus monotherapy in advanced unresectable or metastatic gall bladder cancer progressing on first line chemotherapy (GB-SELECT) |
CTRI/2017/10/010112 |
Analysis Ongoing |
Medical Oncology |
Gastro Intestinal |
| 1875 |
Dr. Prachi Patil |
A comparison of clinicopathological profile of non-B non-C hepatocellular cancer (HCC) and Hepatitis B or C related HCC |
CTRI/2018/06/014535 |
Accrual completed and follow-up ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 2001 |
Dr. Akshay Baheti |
Utility of MRI in detecting peritoneal metastases in gastric cancer patients with negative CECT abdomen |
CTRI/2018/07/015012 |
Active Enrollment ongoing |
Radio-diagnosis |
Gastro Intestinal |
| 2002 |
Dr. Akshay Baheti |
Utility of MRI in evaluation of pancreatic cancer for predicting and assessing response to neoadjuvant chemotherapy: A prospective observational study |
|
Not started/Not initiated |
Radio-diagnosis |
Gastro Intestinal |
| 2025 |
Dr. Prachi Patil |
Prevalence and predictors of malnutrition and its impact on quality of life and prognosis in patients with hepato-biliary tumors - a prospective study |
CTRI/2018/05/014215 |
Accrual completed and follow-up ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 2026 |
Dr. Prachi Patil |
Prevalence and predictors of malnutrition and its impact on quality of life and prognosis in patients with pancreatic tumours - a prospective study |
2018/05/013859 |
Accrual completed and follow-up ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 3029 |
Dr. Shailesh Shrikhande |
An integrated network analysis to identify genomic alteration profiles of human periampullary cancer |
CTRI/2018/08/015556 |
Data Analysis ongoing |
Surgical Oncology |
Gastro Intestinal |
| 3033 |
Dr. Prachi Patil |
A randomized phase 2/3 trial of Rosuvastatin with neo-adjuvant chemo-radiation in patients with rectal cancer |
CTRI/2018/11/016459 |
Accrual completed and follow-up ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 3063 |
Dr. Sharayu Mhatre |
Prevalence of Gallstone diseases in the regions with the high and low incidence of gallbladder cancer: current status and future perspective for gallbladder cancer prevention |
CTRI/2018/10/016067 |
Data Analysis ongoing |
Centre For Cancer Epidemiology |
Gastro Intestinal |
| 3106 |
Dr. Vikas Ostwal |
A randomized, open label, parallel-group, phase 3 study to investigate the efficacy and tolerability of palonosetron, dexamethasone, aprepitant plus Olanzapine versus palonosetron, dexamethasone and aprepitant alone in patients receiving high moderately emetogenic chemotherapeutic (MEC) regimens (OMEC study). |
CTRI/2018/12/016643 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Gastro Intestinal |
| 3143 |
Dr. Vikas Ostwal |
Two arm, triple blinded, randomized placebo controlled, prospective, parallel design Phase II integrated phase III study to evaluate the role of Carica papaya leaf extract (CPLE) in reducing the duration of chemotherapy induced thrombocytopenia and adverse events related to thrombocytopenia |
CTRI/2019/08/020987 |
Data Analysis ongoing |
Medical Oncology |
Gastro Intestinal |
| 3189 |
Dr. Akshay Baheti |
Role of MRI in rectal cancers: Correlation with histopathology and outcomes |
|
Case review/sample review ongoing (audit studies) |
Radio-diagnosis |
Gastro Intestinal |
| 3202 |
Dr. Rajesh Dikshit |
To elucidate geographical differences in the incidence of gallbladder cancer by identifying etiologically distinct types of gallbladder cancer through the study of mutational signature. |
CTRI/2019/07/020307 |
Data Analysis ongoing |
Centre For Cancer Epidemiology |
Gastro Intestinal |
| 3234 |
Dr. Reena Engineer |
Dose Escalated Radiotherapy and Organ Preservation in Rectal Cancers (DEROP-RC) |
CTRI/2020/03/023943 |
Accrual completed and follow-up ongoing |
Radiation Oncology |
Gastro Intestinal |
| 3243 |
Dr. Reena Engineer |
Neodjuvant treatment versus upfront surgery in Resectable pancreatic cancer (NEVUS) |
CTRI/2019/09/021082 |
Active Enrollment ongoing |
Radiation Oncology |
Gastro Intestinal |
| 3258 |
Dr. Ameya Puranik |
PReCedeNT trial: Phase III randomised-controlled open-label trial of Lutetium - 177 Peptide Receptor Radionuclide Therapy (PRRT) Plus Chemotherapy Versus PRRT alone in FDG-avid, Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors (GEP-NETs) |
CTRI/2019/07/020388 |
Active enrollment ongoing |
Nuclear Medicine |
Gastro Intestinal |
| 3278 |
Mrs. Anita D Souza |
Effect of nurse led intervention on cognitive and non-cognitive functions and serum TNF alpha levels in patients receiving chemotherapy for CRC at Tata Memorial Hospital, Mumbai |
REF/2019/07/027076 |
Data Analysis ongoing |
Nursing Services |
Gastro Intestinal |
| 3307 |
Dr. Vikas Ostwal |
Protocol No. - D933GC00001 : A Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Transarterial Chemoembolization (TACE) in Combination with either Durvalumab Monotherapy or Durvalumab plus Bevacizumab Therapy in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-1) |
CTRI/2019/03/018124 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Gastro Intestinal |
| 3356 |
Dr. Vikas Ostwal |
A study of HCC correlating its biology with Clinico demographic and ethnic features along with its Survival outcomes |
CTRI/2020/02/2023363 |
Data Analysis ongoing |
Medical Oncology |
Gastro Intestinal |
| 3381 |
Dr. Anant Ramaswamy |
Bevacizumab plus Erlotinib maintenance therapy versus observation in advanced biliary tract cancers - a two arm open label prospective integrated Phase II/Phase III parallel design superiority clinical trial. |
CTRI/2020/03/023943 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3387 |
Dr. Anuradha Mehta |
A randomized, double blinded, parallel-group, phase 3 study to investigate the efficacy and tolerability of palonosetron, dexamethasone, aprepitant plus oral cannabinoid versus palonosetron, dexamethasone and aprepitant alone in patients receiving highly emetogenic chemotherapeutic (HEC) regimens |
CTRI/2020/03/024106 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3406 |
Dr. Sridhar Sundaram |
An open label, prospective three-arm randomized, non-comparative study on efficacy and tolerability of orally disintegrating strip, oral tablets and intravenous administration of Vitamin B12, in post-gastrectomy Indian patients |
CTRI/2020/02/023450 |
Active Enrollment ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 3419 |
Dr. Anant Ramaswamy |
Adjuvant chemotherapy for operated amPullary AdenoCarcinomas based on Histology and Intensification ; A two arm non - randomized open label prospective parallel adaptive design phase II clinical trial (APACHI) |
CTRI/2020/05/025353 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3490 |
Dr. Prachi Patil |
A prospective pilot study to assess the effect of Resveratrol-Copper on the viral load in patients with Chronic Hepatitis B and C virus infection |
CTRI/2023/05/053055 |
Active Enrollment ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 3491 |
Dr. Reena Engineer |
Pilot testing of the Hindi and Marathi translations of the European Organization for the Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire module for patients with Colorectal Cancers (CR-29)_x000D_\n |
CTRI/2022/043749 |
Data Analysis ongoing |
Radiation Oncology |
Gastro Intestinal |
| 3506 |
Dr. Sridhar Sundaram |
Pattern of microbial dysbiosis in gastric cancer- A multicentric study |
CTRI/2021/10/037657 |
Data Analysis ongoing |
Medical Oncology |
Gastro Intestinal |
| 3610 |
Dr. Suyash Kulkarni |
Protocol No. - LUF-44-005 : Safety and Efficacy of Transarterial Chemoembolization with Lipiodol® in the treatment of inoperable Hepatocellular Carcinoma (HCC) in Indian Patients: Phase IV Clinical Trial. |
CTRI/2020/10/028544 |
Data Analysis ongoing |
Radio-diagnosis |
Gastro Intestinal |
| 3649 |
Dr. Vikas Ostwal |
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study of Durvalumab Monotherapy or in Combination with Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (EMERALD-2). |
CTRI/2021/01/030856 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Gastro Intestinal |
| 3657 |
Dr. Avanish Saklani |
Surgical and patient-entered experiences following urinary reconstruction after pelvic exenteration for locally advanced and recurrent rectal cancer |
CTRI/2022/01/03944 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 3677 |
Mrs. Anita D Souza |
Evaluation of the effect of foot bathing on peripheral neuropathy in patients receiving oxaliplatin containing chemotherapy for GI cancer at Tata Memorial Hospital |
CTRI/2021/04/032906 |
Active Enrollment ongoing |
Nursing Services |
Gastro Intestinal |
| 3702 |
Dr. Anant Ramaswamy |
A phase I study of oral metronomic capecitabine with cyclophosphamide as maintenance therapy in patients with chemotherapy responsive advanced colorectal cancers . |
CTRI/2022/01/039157 |
Data Analysis ongoing |
Medical Oncology |
Gastro Intestinal |
| 3736 |
Dr. Avanish Saklani |
BIDIRECTIONAL INTRAPERITONEAL CHEMOTHERAPY ALONG WITH SYSTEMIC CHEMOTHERAPY IN ADENOCARCINOMA OF RECTUM WITH ISOLATED PERIOTNEAL METASTASIS - A PROSPECTIVE STUDY |
CTRI/2023/11/059575 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 3741 |
Dr. Prabhat Bhargava |
A randomized, open-label, double arm, phase III study of doublet vs monotherapy in advanced pancreatic cancer who have failed first-line therapy. |
CTRI/2022/02/040235 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3743 |
Dr. Prabhat Bhargava |
Arsenic trioxide (ATO) plus FOLFIRI vs. Irinotecan monotherapy as second-line therapy in advanced Colorectal Cancers - a randomized non-blinded two-arm Phase II prospective (ATaCC study). |
CTRI/2022/06/043304 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3751 |
Dr. George John |
A randomized, double blinded , parallel group, placebo controlled , phase III randomized trial to evaluate the efficacy of Resveratrol-copper in patients receiving 5-Fluorouracil based chemotherapy regimens to reduce grade 3- 5 Muco-cutaneous toxicities. (ReForM study) |
CTRI/2023/07/055750 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3782 |
Dr. Akshay Baheti |
Diagnostic performance of Diffusion-weighted imagingin the detection of residual tumor after neoadjuvant chemoradiation in rectal adenocarcinoma: A prospective multicentric study_x000D_\n |
|
Case review/sample review ongoing (audit studies) |
Radio-diagnosis |
Gastro Intestinal |
| 3785 |
Dr. Anant Ramaswamy |
A randomized phase III clinical trial evaluating the non-inferiority of reduced dose chemotherapeutic regimens based on CARG risk scores compared to standard doses in Older patients with advanced esophageal, esophagogastric, gastric, and biliary tract cancers (CARGO study) |
CTRI/2022/03/040884 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3789 |
Dr. Prabhat Bhargava |
A two-arm randomized phase III, open-label prospective non-inferiority study of irinotecan versus oxaliplatin / 5-FU based chemotherapy (mFOLFOX/CAPOX) for patients with locally advanced/ metastatic biliary tract cancers (BTC) previously treated with gemcitabine-based chemotherapy._x000D_\n |
CTRI/2022/01/039568 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3803 |
Dr. Sohan Solanki |
Effect of Terlipressin in Patients Undergoing Major Hepatectomies for Liver Cancers: A Prospective Randomized Controlled Phase-III Trial (TerliHep Trial) |
CTRI/2021/11/038076 |
Active Enrollment ongoing |
Anaesthesia |
Gastro Intestinal |
| 3833 |
Dr. Vikas Ostwal |
An Open-label, Multicenter, Randomized Phase 3 Study of First line Encorafenib Plus Cetuximab With or Without Chemotherapy versus Standard of Care Therapy with a Safety Lead-in of Encorafenib and Cetuximab Plus Chemotherapy In Participants with Metastatic BRAF V600E Mutant Colorectal Cancer |
CTRI/2021/10/037186 |
Active accrual and intervention ongoing |
Medical Oncology |
Gastro Intestinal |
| 3860 |
Dr. Venkatesh Rangarajan |
Protocol No. - DP-1111-02CT : A Prospective, Randomized, Controlled, Open-label, Multicenter Trial to Evaluate Efficacy, Safety and Patient-reported Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) with Lutetium (177Lu) Edotreotide compared to Best Standard of Care in Patients with Well-differentiated Aggressive Grade 2 and Grade 3, Somatostatin Receptor-positive (SSTR+), Neuroendocrine Tumors of GastroEnteric or Pancreatic Origin (COMPOSE) |
CTRI/2021/12/038483 |
Accrual completed and follow-up ongoing |
Nuclear Medicine |
Gastro Intestinal |
| 3878 |
Dr. Sohan Solanki |
PErioperative respiratory care and outcomes for patieNts Undergoing hIgh risk abdomiNal surgery |
CTRI/2020/08/027348 |
Active Enrollment ongoing |
Anaesthesia |
Gastro Intestinal |
| 3880 |
Dr. Avanish Saklani |
Early versus delayed stoma reversal after rectal cancer resections - A randomized controlled trial_x000D_\n_x000D_\n |
CTRI/2022/12/048069 |
Active Enrollment ongoing |
Surgical Oncology |
Gastro Intestinal |
| 3934 |
Dr. Shrikant Raut |
Comparing clinical utility of serum CA 72-4 level with CEA and CA 19-9 in monitoring gastric cancer treatment. |
CTRI/2022/10/046470 |
Active Enrollment ongoing |
Biochemistry |
Gastro Intestinal |
| 3962 |
Dr. George John |
Physician choice Multi-agent chemotherapy versus Gemcitabine monotherapy for advanced Pancreatic adenocarcinomas in frail or Elderly patients - a randomized phase III clinical trial (MAGPiE Trial)._x000D_\n_x000D_\n |
CTRI/2022/12/048500 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 3965 |
Dr. Reena Engineer |
DOSIMETRIC COMPARISON BETWEEN PHOTON SBRT VS IMPT (PROTON THERAPY) IN LAPC FOLLOWED BY PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS OF LAPC TREATED WITH PROTON THERAPY |
|
Not started/Not initiated |
Radiation Oncology |
Gastro Intestinal |
| 3972 |
Dr. Vikram Chaudhary |
Utility of mesopancreas triangle clearance with level 2 mesopancreas dissection in pancreaticoduodectomy for resectable periampullary carcinomas |
CTRI/2022/11/046981 |
Data Analysis ongoing |
Surgical Oncology |
Gastro Intestinal |
| 3981 |
Dr. Manjunath Nookala |
Update of the EORTC QLQ-PAN26 questionnaire for the assessment of health-related quality of life (HRQoL) in patients with pancreatic adenocarcinoma. |
CTRI/2022/07/043965 |
Data Analysis ongoing |
Clinical Pharmacology |
Gastro Intestinal |
| 3986 |
Dr. Ameya Puranik |
DISCOUNT Trial: Early Intervention versus Observation in Low grade GEP-NET - A Feasibility Study _x000D_\n_x000D_\n |
|
Active Enrollment ongoing |
Nuclear Medicine |
Gastro Intestinal |
| 4046 |
Dr. Anant Ramaswamy |
Protocol No. - 20-VIN-0570 : A single arm, open label, multiple ascending dose, prospective, multicentre study to assess safety, tolerability, pharmacokinetics and pharmacodynamic of PNB028 (Test, manufactured by PNB Vesper Life Science Pvt. Ltd., India) in colon or pancreatic cancer patients. |
CTRI/2024/01/062125 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4059 |
Dr. Vikas Ostwal |
Protocol No. - D910VC00001 : A Phase III, Randomized, Open-Label, Sponsor-Blinded, Multicenter Study of Durvalumab in Combination with Tremelimumab ± Lenvatinib Given Concurrently with Transarterial Chemoembolization (TACE) Compared to TACE Alone in Patients with Locoregional Hepatocellular Carcinoma (EMERALD-3) |
CTRI/2022/07/044432 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Gastro Intestinal |
| 4077 |
Dr. Subhash Yadav |
RAPPORT Study: RAdio-Pathological correlation of POst neoadjuvant resections of Rectal Tumors |
|
Data Analysis ongoing |
Pathology |
Gastro Intestinal |
| 4084 |
Dr. Vikas Ostwal |
Retrospective analysis of tolerance to and outcomes with Bevacizumab (Originator or Biosimilar) in metastatic colorectal cancers at TMC between 2014 and 2021_x000D_\n_x000D_\n |
|
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4090 |
Dr. Vikas Ostwal |
A retrospective analysis of prognostic factors and outcomes of Biliary Tract Cancers treated in TMH/ACTREC between January 2018 to December 2023._x000D_\n_x000D_\n_x000D_\n |
|
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4105 |
Dr. Prabhat Bhargava |
TAS-102 plus BEvacizumab vs Regorafenib in chemotherapy-refractory advanced colorectal cancers - a randomized non-blinded two-arm Phase III prospective clinical trial (TARt study). |
CTRI/2023/04/051850 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4116 |
Dr. Vikas Ostwal |
Retrospective analysis of Survival Outcomes of Locally advanced rectal cancers (LARC) undergoing chemoradiation (SOLAR study) |
|
Data Analysis ongoing |
Medical Oncology |
Gastro Intestinal |
| 4124 |
Dr. Ameya Puranik |
Analysis of Ga 68 DOTANOC PET/CT and F18 FDG PET/CT studies in patients with Neuro-endocrine Tumors: correlation with outcome_x000D_\n_x000D_\n |
|
Accrual completed and follow-up ongoing |
Nuclear Medicine |
Gastro Intestinal |
| 4130 |
Dr. Mahesh Goel |
Retrospective international multicenter study to validate the difficulty scoring system and develop a novel scoring system for laparoscopic and robotic liver resections |
CTRI/2025/05/086498 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4145 |
Dr. Shivakumar Gudi |
Systemic therapy with or without Radiation Therapy in Unresectable nonmetastatic Gall Bladder Carcinoma: Open label, Parallel arm, Phase 2/3 integrated randomized clinical trial (RUGB) |
CTRI/2024/01/061609 |
Active accrual and intervention ongoing |
Radiation Oncology |
Gastro Intestinal |
| 4153 |
Mrs. Anita D Souza |
'Effects of topical application of urea with aloevera cream on handfoot syndrome in GI cancer patients receiving 5FU. A randomized controlled trial.''. |
|
Approved |
Nursing Services |
Gastro Intestinal |
| 4168 |
Dr. Sohan Solanki |
A prospective randomized comparison between passive hypothermia and normothermia before starting HIPEC on rebound hypothermia after intraperitoneal hyperthermic chemotherapy_x000D_\n_x000D_\n |
CTRI/2023/06/069301 |
Data Analysis ongoing |
Anaesthesia |
Gastro Intestinal |
| 4170 |
Dr. Vikas Ostwal |
A Single-arm phase II prospective open-label interventional study in 1st line therapy for patients with Metastatic colorectal cancer (MSI-H) with low-dose Nivolumab (CLOuD) |
CTRI/2024/01/061681 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4172 |
Dr. Vikas Ostwal |
Trastuzumab plus chemotherapy vs Chemotherapy alone in first-line HER2 positive advanced biliary tract cancer patients - a randomized non-blinded two-arm Phase III prospective clinical trial (TAB - 2 study)_x000D_\n_x000D_\n |
CTRI/2023/07/055523 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4189 |
Dr. Ashwin Desouza |
Incidence of nodal positivity in the Surgical trunk of Gillot (STG)- a retrospective and prospective observational study |
CTRI/2024/11/076265 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4190 |
Dr. Prachi Patil |
Prevalence and Risk Factors for Colorectal Polyps/Cancers in Indian Population: A Prospective Multicentre Study. |
CTRI/2023/05/052469 |
Active Enrollment ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 4192 |
Dr. Vikas Ostwal |
Efficacy and Safety of Oral LactoferrIn and Disodium guanosine monophosphate (dGMP) supplementation for the treatment of cancer-related anemia in Advanced Cancer Patients Undergoing Chemotherapy- A Randomized phase III Placebo-Controlled double-blinded Study (a SOLiD trial). |
In Process |
Not started/Not initiated |
Medical Oncology |
Gastro Intestinal |
| 4196 |
Dr. Anant Ramaswamy |
Multi-institutional retrospective analysis of outcomes in Indian patients with advanced/metastatic colorectal cancers treated between 2016 and 2022 |
|
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4197 |
Dr. Rahul Krishnatry |
Evaluating the Use of Patient-Reported Outcome Measures for Improving the Inter-Rater Reliability of Common Terminology Criteria for Adverse Event Ratings |
CTRI/2023/10/058202 |
Active Enrollment ongoing |
Radiation Oncology |
Gastro Intestinal |
| 4198 |
Dr. Ameya Puranik |
Dual 68-Ga DOTATATE and 18-F FDG PET/CT imaging in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: validation of NETPET score. |
|
Data Analysis ongoing |
Nuclear Medicine |
Gastro Intestinal |
| 4202 |
Dr. Anant Ramaswamy |
Retrospective analysis of Gastrointestinal Neuroendocrine Carcinomas treated in TMH between May 2014 & May 2022. |
|
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4204 |
Dr. Avanish Saklani |
FOxTROT 2 India: A randomised pilot trial evaluating neoadjuvant chemotherapy in older and/or frail patients with locally advanced but operable colon cancer |
CTRI/2023/07/055141 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4217 |
Dr. Avanish Saklani |
Circular stapled end colostomy versus conventional end colostomy creation in patients undergoing a permanent stoma - A randomized controlled trial |
059362 |
Active Enrollment ongoing |
Surgical Oncology |
Gastro Intestinal |
| 4219 |
Dr. Vikram Chaudhary |
Impact of a positive resection margin on outcomes of distal pancreatic cancers in the era of standardized pathology reporting and neoadjuvant therapy |
|
Data Analysis ongoing |
Surgical Oncology |
Gastro Intestinal |
| 4224 |
Dr. Mahesh Goel |
GLOBAL EVALUATION OF CHOLECYSTECTOMY KNOWLEDGE AND OUTCOMES (GEKCO) |
CTRI/2024/01/061743 |
Accrual completed and follow-up ongoing |
Surgical Oncology |
Gastro Intestinal |
| 4238 |
Dr. Ameya Puranik |
FAP-1 Study: FAPi PET in Pancreatic Ductal Adenocarcinoma: A Prospective Exploratory Study |
|
Active Enrollment ongoing |
Nuclear Medicine |
Gastro Intestinal |
| 4244 |
Dr. Manish Bhandare |
Peri-operative cannabis use in patients undergoing pancreaticoduodenectomy for pancreatic and periampullary carcinoma: A phase II/III open label randomized controlled study |
CTRI/2025/03/081899 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4263 |
Dr. Subhash Yadav |
Clinicopathological correlation of tumour regression grades (TRG) in gastric carcinoma after neoadjuvant chemotherapy (NACT) and comparison between various tumor regression grading systems: A retrospective cohort study |
|
Data Analysis ongoing |
Pathology |
Gastro Intestinal |
| 4264 |
Dr. Manish Bhandare |
The feasibility and acceptability of conducting a randomised controlled trial to improve Body Composition and Quality of Life of stomach cancer patients after Total gastrectomy in India (EASE IN)_x000D_\n_x000D_\n _x000D_\n_x000D_\n |
CTRI/2024/04/065062 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4278 |
Dr. Anant Ramaswamy |
Gemcitabine-cisplatin-albumin bound paclitaxel (GAP) versus gemcitabine-platinum (GP) in advanced gallbladder cancers (GBC) - a randomized parallel design phase III clinical trial (GAP-GB) |
CTRI/2024/01/061479 |
Active accrual and intervention ongoing |
Medical Oncology |
Gastro Intestinal |
| 4307 |
Dr. Rahul Krishnatry |
Ambispective Observational Study for Locally Advanced Rectal Cancer Patients Suitable for Wait and Watch Treated with Total Neoadjuvant Therapy (ARROW) |
CTRI/2024/02/062583 |
Active enrollment ongoing |
Radiation Oncology |
Gastro Intestinal |
| 4308 |
Dr. Avanish Saklani |
International Benchmarking Study of Pelvic Exenteration for Rectal Cancer: (BeSt-PE) |
CTRI/2024/09/073200 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4319 |
Dr. Avanish Saklani |
Mapping the signet-ring cell colorectal cancer epidemic in India - A spatial epidemiology study |
CTRI/2024/02/063324 |
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4334 |
Dr. Sohan Solanki |
A Randomised Controlled Trial of Effect of Propofol based Total Intravenous Anaesthesia Versus Sevoflurane based Inhalational Anaesthesia on VEGF-C and TGF-beta Levels after Radical Gall Bladder Cancer Surgery |
CTRI/2024/02/063208 |
Active Enrollment ongoing |
Anaesthesia |
Gastro Intestinal |
| 4336 |
Dr. Rahul Krishnatry |
Phase III Randomised Control Trial of Intensity-Modulated Radiotherapy using Photon Versus Proton with Concurrent Chemotherapy for Locally Advanced Anal Canal Cancer (IMPAC) |
CTRI/2024/05/066687 |
Not started/Not initiated |
Radiation Oncology |
Gastro Intestinal |
| 4340 |
Dr. Anant Ramaswamy |
Understanding the molecular changes between primary and metastatic lesions of pancreatic cancer |
NA |
Not started/Not initiated |
Medical Oncology |
Gastro Intestinal |
| 4342 |
Dr. Sridhar Sundaram |
Randomized trial comparing endoscopic ultrasound-guided gastrojejunostomy and surgical gastrojejunostomy in gastric outlet obstruction |
CTRI/2024/04/082767 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4344 |
Dr. Avanish Saklani |
A phase II Randomized controlled trial comparing short-course radiation and chemotherapy with or without intraperitoneal paclitaxel for locally advanced, non-metastatic signet-ring cell rectal cancers. |
CTRI/2024/04/065785 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4368 |
Dr. Vikas Ostwal |
Prevalence of Claudin 18.2 in gastric and biliary tract cancers |
|
Data Analysis ongoing |
Medical Oncology |
Gastro Intestinal |
| 4372 |
Dr. Rahul Krishnatry |
A feasibility study to develop a HRQoL module for metastatic and recurrent/ persistent anal cancer or to add metastatic anal cancer-specific items to the existing EORTC QLQ-ANL27 |
CTRI/2024/04/066464 |
Active Enrollment ongoing |
Radiation Oncology |
Gastro Intestinal |
| 4381 |
Dr. Shailesh Shrikhande |
PRIME: Portal vein Resection- Indian MulticentrE study |
|
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4398 |
Dr. Prachi Patil |
'Anonymized patient survey on hepatocellular carcinoma (HCC) surveillance practices in India'' |
CTRI/2024/09/073208 |
Active Enrollment ongoing |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 4399 |
Dr. Vikas Ostwal |
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01) |
CTRI/2024/02/063127 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4407 |
Dr. Vikas Ostwal |
A Multi-Center, Single Arm, Phase IV Study to Assess the Safety and Efficacy of Lenvatinib Capsules for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer OR for the First Line Treatment of Patients with Unresectable Hepatocellular Carcinoma |
CTRI/2023/05/052759 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4416 |
Dr. Shraddha Patkar |
CT-based Deep Learning in Gallbladder Cancer: A multicenter study |
|
Data Analysis ongoing |
Surgical Oncology |
Gastro Intestinal |
| 4417 |
Dr. Vikas Ostwal |
Perioperative Gemcitabine based chemotherapy versus upfront resection followed by adjuvant capecitabine with and chemo-radiation in operable Stage III Gall bladder cancers (GBC) -_x000D_\n_x000D_\n A Randomised, open-label, Two-Arm phase III Prospective Clinical Trial (GB-GeCCOR II) |
CTRI/2024/08/072162 |
Not started/Not initiated |
Medical Oncology |
Gastro Intestinal |
| 4421 |
Dr. Munita Bal |
A multi-omics approach to dissect the molecular mechanisms of early-onset colorectal cancer in the Indian population |
|
Approved |
Pathology |
Gastro Intestinal |
| 4435 |
Dr. Shivakumar Gudi |
Evaluation of clinical outcome in Asian patients with localised rectal adenocarcinoma managed with watch-and-wait approach by developing a multinational collaborative database_x000D_\n_x000D_\n |
CTRI/2024/10/074809 |
Active Enrollment ongoing |
Radiation Oncology |
Gastro Intestinal |
| 4443 |
Dr. Vikas Ostwal |
The ABC-HCC Trial : A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterialChemoembolization (TACE) in intermediate-stage HepatoCellularCarcinoma |
CTRI/2024/11/077188 |
Active Enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4450 |
Dr. Rajiv Kumar |
A Multi-Cancer Study for Assessment of Artificial Intelligence Algorithms for Detection of Lymph Node Metastasis |
|
Active accrual and intervention ongoing |
Pathology |
Gastro Intestinal |
| 4451 |
Dr. Reena Engineer |
Radiomic feature extraction and its clinical relevance in pancreatic malignancy post SBRT_x000D_\n_x000D_\n |
|
Data Analysis ongoing |
Radiation Oncology |
Gastro Intestinal |
| 4455 |
Dr. Shraddha Patkar |
FAP-2 trial: Utility of gallium-68-Fibroblast Activation Protein Inhibitor (FAPi) PET in Biliary Tract Cancers: A Prospective Study |
CTRI/2024/09/073350 |
Active Enrollment ongoing |
Surgical Oncology |
Gastro Intestinal |
| 4461 |
Dr. Shailesh Shrikhande |
Multicenter Retrospective Analysis of Adjuvant Chemotherapy Regimen in Intraductal Papillary_x000D_\nMucinous Neoplasms [IPMN] derived Pancreatic Ductal Adenocarcinoma [PDAC] |
CTRI/2024/10/076077 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4467 |
Dr. Amitkumar Choudhari |
Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer. |
|
Approved |
Radio-diagnosis |
Gastro Intestinal |
| 4483 |
Dr. Sridhar Sundaram |
Endoscopic ultrasound guided gastroenterostomy versus Enteral stenting in the palliation of malignant gastric outlet obstruction: A retrospective observational analysis |
|
Approved |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 4491 |
Dr. Avanish Saklani |
Randomised, double blind placebo-controlled trial of peri-adjuvant artesunate in colorectal cancer ( Peri-Art trial) |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4492 |
Dr. Vikas Ostwal |
An open-label randomized trial of the efficacy and safety of zanidatamab with standard-of-care therapy against standard-of-care therapy alone for advanced HER2-positive biliary tract cancer.- JZP598-302 (JZP598-302- Jazz Pharmaceuticals study) |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4498 |
Dr. Ashwin Desouza |
DRAGON Trial: Multicentre non-inferiority cluster randomized trial testing Disposable versus Reusable drapes and gowns for green operating theaters |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4524 |
Dr. Vikas Ostwal |
A randomized, placebo controlled, phase 3, triple blinded study to investigate the efficacy and tolerability of Olanzapine, Aprepitant,IV Dexamethasone and Palanosetron versus Olanzapine, Aprepitant,Palanosetron and placebo in patients receiving moderately emetogenic chemotherapeutic (MEC) regimens (OMEC 2) |
CTRI/2025/02/080952 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4530 |
Dr. Anant Ramaswamy |
The use of immune checkpoint inhibitors in microsatellite stable advanced gastric and gastroesophageal adenocarcinomas - An All India collaborative study |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4533 |
Dr. Vikas Ostwal |
Analysing and solving exceptional long-term survival in patients with poor prognosis solid tumors (ROSALIND STUDY) |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4537 |
Dr. Shailesh Shrikhande |
External validation of the ISGPS classification of High-Risk Pancreas and risk prediction of clinically relevant postoperative pancreatic fistula in periampullary tumours. How well does it hold? |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4541 |
Dr. Vikas Ostwal |
A Prospective, Randomized, Double Blind, Multicentric, Parallel Group Phase-III Clinical Study to Evaluate the Efficacy, Safety, and Immunogenicity of BP01 (Bevacizumab) Versus EU approved Avastin® along with chemotherapy XELOX in metastatic colorectal cancer patients. |
CTRI/2024/04/066032 |
Accrual completed and follow-up ongoing |
Medical Oncology |
Gastro Intestinal |
| 4552 |
Dr. Akshay Baheti |
Accuracy of Contrast Enhanced CT in the evaluation of potentially operable gall bladder lesions |
|
Approved |
Radio-diagnosis |
Gastro Intestinal |
| 4553 |
Dr. Shailesh Shrikhande |
Towards furthering nation-wide access to state-of-the-art pancreatic surgery: impact of an HPB fellowship training program at India's largest dedicated pancreatic unit. |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4554 |
Dr. Anant Ramaswamy |
Phase II, single arm, prospective multicentre interventional study of SBRT(Stereotactic body radiotherapy) and Atezolizumab with Bevacizumab in unresectable Hepatocellular carcinoma |
CTRI/2025/04/084493 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4561 |
Dr. Vikas Ostwal |
A Phase III Multi-center, Open-label, Sponsor-blinded, Randomized Study of AZD0901 Monotherapy Compared with Investigator's Choice of Therapy in Second- or Later-Line Adult Participants with Advanced/Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2: CLARITY GASTRIC 1 |
CTRI/2025/02/080588 |
Active enrollment ongoing |
Medical Oncology |
Gastro Intestinal |
| 4566 |
Dr. Reena Engineer |
Association of HDAC expression with treatment response in rectal cancer patients after Neoadjuvant therapy. |
|
Approved |
Radiation Oncology |
Gastro Intestinal |
| 4570 |
Dr. Avanish Saklani |
Laparoscopic vs robotic lateral pelvic lymph node dissection in locally advanced rectal cancer: a cohort study comparing peri-operative morbidity and short-term oncological outcomes |
CTRI/2024/11/077338 |
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4575 |
Dr. Prabhat Bhargava |
Retrospective analysis of clinical outcome and clinical next-generation sequencing application in malignant peritoneal mesothelioma patients treated in a tertiary cancer care center in India |
CTRI/2025/10/095523 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4588 |
Dr. Shailesh Shrikhande |
Novel Benchmarks for Robotic Whipple - a Retrospective Multicenter Cohort Study |
CTRI/2025/02/080573 |
Not started/Not initiated |
Surgical Oncology |
Gastro Intestinal |
| 4598 |
Dr. Anant Ramaswamy |
Phase 2 study evaluating the addition of immune-sensitizing radiotherapy and biomarker-driven low-dose nivolumab in locally advanced resectable gastroesophageal junction/gastric cancers |
CTRI/2025/02/079994 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4601 |
Dr. Aditya Kale |
Role of prophylactic biliary stent in reducing biliary complications after stone clearance in patients awaiting cholecystectomy-A multicentric randomized controlled trial (STONE trial). |
|
Approved |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 4623 |
Dr. Manju Sengar |
A prospective observational study to evaluate time toxicity in patients receiving palliative systemic anticancer therapy for haematological and advanced metastatic/recurrent cancers. |
CTRI/2025/06/088119 |
Study Initiated and Recruitment Started |
Medical Oncology |
Gastro Intestinal |
| 4626 |
Dr. Anant Ramaswamy |
A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer (OrigAMI-2) |
CTRI/2025/02/080549 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4636 |
Dr. Anant Ramaswamy |
A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wildtype Recurrent, Unresectable or Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy(OrigAMI-3) |
CTRI/2025/01/079039 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4645 |
Dr. Rahul Krishnatry |
QUALITY METRICS FOR RADIOTHERAPY IN RECTAL CANCER |
|
Study Initiated and Recruitment Started |
Radiation Oncology |
Gastro Intestinal |
| 4646 |
Dr. Akshay Baheti |
Added value of Diffusion weighted screening of liver in baseline rectal cancer assessment compared to CECT abdomen |
|
Approved |
Radio-diagnosis |
Gastro Intestinal |
| 4648 |
Dr. Rahul Krishnatry |
Development of the Cancer Patient-reported Symptomatic Adverse Events Inventory (EORTC-PROAE) Using the EORTC Item Library: qualitative interview study. |
|
Approved |
Radiation Oncology |
Gastro Intestinal |
| 4658 |
Dr. Avanish Saklani |
Clinical profile of early onset of rectal cancers in India, A retrospective Audit. |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4659 |
Dr. Shailesh Shrikhande |
Impact of complications on disease recurrence and overall survival after resection of periampullary cancers. |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4663 |
Dr. Shailesh Shrikhande |
Validation of the ISGPS Minimally Invasive Pancreatoduodenectomy complexity and competency grading system: A nationwide snapshot study |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4673 |
Dr. Prachi Patil |
Surveillance of Etiological factors for Cirrhosis and Hepatocellular Carcinoma. |
|
Approved |
Digestive Diseases And Clinical Nutrition |
Gastro Intestinal |
| 4674 |
Dr. Sohan Solanki |
Cancer Related Inflammatory and Systemic nutritional marKers as predictors of postoperative complications and survival after cytoreductive surgery and HIPEC for peritoneal cancers (RISK-HIPEC Study). |
|
Approved |
Anaesthesia |
Gastro Intestinal |
| 4687 |
Dr. Vikas Ostwal |
Small Molecule Inhibitors to overcome Oxaliplatin resistance in first line therapy of advanced colorectal cancers - a prospective, randomized, non-blinded, multi arm Phase IB-IIA study (SOX study) |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4688 |
Dr. Sohan Solanki |
Study of Perioperative Dysglycemia in Upper Abdominal Gastrointestinal and Hepato-Pancreato-Biliary Surgeries and Its Postoperative Adverse Events in Non-Diabetic SuRgical Patients (SUGAR Trial) |
|
Approved |
Anaesthesia |
Gastro Intestinal |
| 4690 |
Dr. Shailesh Shrikhande |
Exploration of Preoperative Predictive Factors for Advanced Neoplasia in Pancreatic Mucinous Cystic Neoplasms |
CTRI/2025/04/085728 |
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4698 |
Dr. Shraddha Patkar |
Correlation of GBRADS USG scoring system with histopathology |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4699 |
Mrs. Anita D Souza |
Effectiveness of monitoring device on compliance to physical activity in survivors of the colorectal cancer |
CTRI/2025/06/088479 |
Study Initiated and Recruitment Started |
Nursing Services |
Gastro Intestinal |
| 4704 |
Dr. Vikas Ostwal |
The impact of contemporary neoadjuvant and adjuvant chemotherapy treatment regimens on recurrence and survival in resectable, borderline resectable, locally advanced and metastatic adenocarcinoma arising from IPMN (A-IPMN) and internal validation of 2023 KYOTO guidelines: ADENO-IPMN 2 study |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4710 |
Dr. Shraddha Patkar |
Yield and clinical utility of peritoneal cytology in patients with locally advanced gallbladder carcinoma undergoing staging laparoscopy |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4722 |
Dr. Reena Engineer |
Short course radiotherapy with chemotherapy vs Long course Chemoradiotherapy in Locally advanced rectal cancers: A Propensity Score Matched pair analysis |
|
Approved |
Radiation Oncology |
Gastro Intestinal |
| 4725 |
Dr. Mahesh Goel |
To evaluate quality of life (QOL) in patients undergoing multivisceral resections and/or vascular resections for retroperitoneal sarcomas. |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4730 |
Dr. Mahesh Goel |
COmparison of the Resection SIte order in simultaneous approach of COlorectal liver metastasis. An international multicentric retrospective trial (CORSICO Study) |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4732 |
Dr. Vikas Ostwal |
Phase 2, randomized, investigator initiated clinical study of Toripalimab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in participants with HER2 negative, previously untreated, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (TORCH-GO) |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4736 |
Dr. Vikas Ostwal |
A Phase II Single-Arm Trial to Evaluate the Efficacy of Low-Dose Nivolumab (40 mg) as Neoadjuvant Treatment in MSI-High Locally Advanced Rectal Cancer (LARgE CLOuD) |
CTRI/2025/07/090631 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4737 |
Dr. Shraddha Patkar |
Risk stratification for patients with First LOcal Recurrence of RetroperitoneAl Liposarcoma (FLORRAL) |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4741 |
Dr. Vikas Ostwal |
A Phase 1b/2, Open-label, Randomized, Multicenter Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients with HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (BHARAT-2) |
CTRI/2025/03/081909 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4747 |
Dr. Shailesh Shrikhande |
To conduct a retrospective multicenter cohort study to define benchmark values for best achievable outcomes following total pancreatectomy (TP)._x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4748 |
Dr. Subhash Yadav |
Clinicopathological Correlation, Audit of Reporting for Standardization and Digital Archiving of Colorectal Cancers - CARD study |
|
Approved |
Pathology |
Gastro Intestinal |
| 4755 |
Dr. Anant Ramaswamy |
PHASE 1B, OPEN-LABEL, DOSE ESCALATION AND COHORT EXPANSIONS TRIAL OF NAPTUMOMAB ESTAFENATOX (NAP, ABR-217620) IN COMBINATION WITH DURVALUMAB (MEDI4736) IN SUBJECTS WITH SELECTED ADVANCED OR METASTATIC SOLID TUMORS |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4758 |
Dr. Vikas Ostwal |
A prospective, multicenter, Open labelled, Phase IV study to establish the Safety & efficacy of Biosimilar Bevacizumab of Enzene Biosciences Ltd. in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer. |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4760 |
Dr. Mahesh Goel |
Preoperative risk assessment for post-hepatectomy liver failure (PHLF) by Future liver remnant (FLR), indocyanine green (ICG), Albumin-Bilirubin (ALBI) score and Aspartate Aminotransferase to platelet-ratio (APRI) score, Fibroscan and development of a model predicting PHLF using all modalities. |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4774 |
Dr. Purvi Haria |
Pattern of variations in superior mesenteric artery branches_x000D_\n_x000D_\n |
|
Approved |
Radio-diagnosis |
Gastro Intestinal |
| 4778 |
Dr. Vikas Ostwal |
A Randomized, Phase III Study of Rilvegostomig in Combination with Fluoropyrimidine and Trastuzumab Deruxtecan versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First-line Treatment of HER2-positive Gastric Cancer (ARTEMIDE Gastric01) |
CTRI/2025/07/091729 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4780 |
Dr. Shailesh Shrikhande |
Predictors of tumour response to neoadjuvant chemotherapy in resected PDACs |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4783 |
Dr. Shraddha Patkar |
Impact of immunonutrition in Patients Undergoing Hepatectomies for Liver Tumors: A Randomized Controlled Phase II Trial |
CTRI/2025/06/088908 |
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4786 |
Dr. Vikram Chaudhary |
Survival outcomes in metastatic and recurrent GISTs after CRS: A Single Centre Experience of 75 Patients_x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4811 |
Dr. Vikram Chaudhary |
Role of HIPEC in isolated cytology positive gastric cancer |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4815 |
Dr. Vikas Ostwal |
DESTINY-Biliary Tract Cancer-01: A Phase 3 Study of Trastuzumab Deruxtecan (T-DXd) and Rilvegostomig versus Standard-of-Care Gemcitabine, Cisplatin, and Durvalumab for First Line Locally Advanced or Metastatic HER2-expressing Biliary Tract Cancer. |
CTRI/2025/09/094936 |
Approved |
Medical Oncology |
Gastro Intestinal |
| 4816 |
Dr. Mahesh Goel |
Development and Validation of Nomogram Predicting Survival In Resectable Gallbladder Cancer |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4819 |
Dr. Ameya Puranik |
FAP -3: FAPi PET in Grade 3 Gastro-entero-pancreatic Neuroendocrine neoplasms: A Prospective, Feasibility Study |
|
Approved |
Nuclear Medicine |
Gastro Intestinal |
| 4822 |
Dr. Shraddha Patkar |
Extended resections for Locally advanced gallbladder cancer amidst multi-modality treatment paradigms: A report on peri-operative and survival outcomes |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4832 |
Dr. Shraddha Patkar |
The Role of Serial Serum Carbohydrate Antigen 19-9 Surveillance to Detect Recurrences after Radical Curative Resection for Gallbladder Carcinoma |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4833 |
Dr. Shailesh Shrikhande |
Multivisceral Oncological Resections Involving the Pancreas - An International Multicenter Study - MORIP-AIMS_x000D_\n_x000D_\n |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4834 |
Dr. Mahesh Goel |
Post-Hepatectomy Early Recurrences in Hepatocellular Carcinoma: Patterns and Treatment Approaches in the Indian Subcontinent |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4835 |
Dr. Mahesh Goel |
Defining the role of Staging Laparoscopy in the diagnostic algorithm of gallbladder cancers |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4846 |
Dr. Manish Bhandare |
Clinical outcomes of Solid Pseudopapillary Epithelial Neoplasms (SPEN) of the Pancreas after Surgical Resection: A retrospective multicentre cohort study |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4848 |
Dr. Indraja Dev |
Phase II study to evaluate safety and efficacy of Lu177 FAPi therapy In patients with relapsed/refractory metastatic gAsTric carcinomas patients. (FIAT STUDY) |
|
Approved |
Nuclear Medicine |
Gastro Intestinal |
| 4869 |
Dr. Anant Ramaswamy |
Maintenance Olaparib for BRCA-Mutated Advanced Gastric Adenocarcinomas (MOBAG trial) |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4874 |
Dr. Shivakumar Gudi |
Outcome of Local Radiation Therapy in Oligo-Recurrent Biliary Tract Cancers. |
|
Approved |
Radiation Oncology |
Gastro Intestinal |
| 4875 |
Dr. Anant Ramaswamy |
Development of a new prediction score (CARG-GI) for chemotherapy toxicity in older patients with gastrointestinal cancer- A multicenter, prospective study |
|
Approved |
Medical Oncology |
Gastro Intestinal |
| 4912 |
Dr. Manish Bhandare |
Outcomes and recurrence patterns following resection of T1 ampullary carcinomas: Single Centre experience of 92 cases |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4920 |
Dr. Shraddha Patkar |
The impact of primary tumour location and molecular profile on recurrence patterns following liver resection for colorectal liver metastases (CRLM): a multicentre cohort study (BIO-CRLM Study) |
|
Approved |
Surgical Oncology |
Gastro Intestinal |
| 4939 |
Dr. Vikram Chaudhary |
Refining treatment algorithms and Optimizing treatment outcomes: The impact of Multidisciplinary NET clinic |
|
Approved |
Surgical Oncology |
Gastro Intestinal |